# Caspase-8 and BID Caught in the Act with Cardiolipin: A New Platform to Provide Mitochondria with Microdomains of Apoptotic Signals

**Authors:** Patrice X. Petit

PMC · DOI: 10.3390/cells14211678 · 2025-10-27

## TL;DR

This paper explores how BID and caspase-8 interact with cardiolipin on mitochondria to trigger cell death signals.

## Contribution

The paper introduces a new platform involving cardiolipin, caspase-8, and BID in mitochondrial apoptosis.

## Key findings

- BID and caspase-8 form a platform on the outer mitochondrial membrane that generates tBID.
- tBID disrupts mitochondrial bioenergetics and promotes cell death signaling.
- Biophysical studies reveal how tBID insertion destabilizes mitochondrial function.

## Abstract

Mitochondria play a central role in cellular bioenergetics. They contribute significantly to ATP production, which is essential for maintaining cells. They are also key mediators of various types of cell death, including apoptosis, necroptosis, and ferroptosis. Additionally, they are one of the main regulators of autophagy. This brief review focuses on BID, a molecule of the BCL-2 family that is often overlooked. The importance of the cardiolipin/caspase-8/BID-FL platform, which is located on the surface of the outer mitochondrial membrane and generates tBID, will be emphasized. tBID is responsible for BAX/BAK delocalization and oligomerization, as well as the transmission of death signals. New insights into the regulation of caspase-8 and BID have emerged, and this review will highlight their originality in the context of activation and function. The focus will be on results from biophysical studies of artificial membranes, such as lipid-supported monolayers and giant unilamellar vesicles containing cardiolipin. We will present the destabilization of mitochondrial bioenergetics caused by the insertion of tBID at the mitochondrial contact site, as well as the marginal but additive role of the MTCH2 protein, not forgetting the new players.

## Linked entities

- **Genes:** BID (BH3 interacting domain death agonist) [NCBI Gene 637], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578], MTCH2 (mitochondrial carrier 2) [NCBI Gene 23788]
- **Proteins:** casp8 (caspase 8, apoptosis-related cysteine peptidase), BID (BH3 interacting domain death agonist), BAX (BCL2 associated X, apoptosis regulator), BAK1 (BCL2 antagonist/killer 1), MTCH2 (mitochondrial carrier 2)
- **Chemicals:** cardiolipin (PubChem CID 166177218)

## Full-text entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578] {aka BAK, BAK-LIKE, BCL2L7, CDN1}, MTCH2 (mitochondrial carrier 2) [NCBI Gene 23788] {aka HSPC032, MIMP, SLC25A50}, BID (BH3 interacting domain death agonist) [NCBI Gene 637] {aka FP497}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}
- **Chemicals:** tBID (-), ATP (MESH:D000255), Cardiolipin (MESH:D002308), lipid (MESH:D008055)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12609577/full.md

---
Source: https://tomesphere.com/paper/PMC12609577